Researching investing ideas in nanotechnology stocks? Look no further! Investorideas.com offers a free stock directory to help you get started.
Investors and traders, sign up for news alerts and make this your starting point for investing in these nanotechnology stocks.
For public nanotechnology companies - If your company is listed, you can request to update your description. Not listed? Email us to learn more about our services and how we can help tell your story to investors in the sector.
180 Degree Capital Corp. - (NASDAQ: TURN)
180 Degree Capital, formerly Harris & Harris, invests in nanotechnology and microsystems firms, with $70 million in assets under management. In 2025, it reports 10% portfolio growth, focusing on undervalued nanotech startups (web ID: 2). Its venture capital model positions it for the $332.7 billion nanotechnology market, leveraging early-stage innovation, though small-cap volatility poses risks.
BASF SE - (Xetra: BAS.DE), (OTC: BASFY)
BASF, a global chemical leader, develops nanomaterials for agriculture and coatings, with €68.9 billion in 2024 revenue. In 2025, it reports 4% growth in nanotech-based pesticides (web ID: 1). Its $2 billion R&D budget positions it for the $332.7 billion nanotechnology market, though regulatory hurdles in agriculture pose risks (web ID: 1).
C-Bond Systems, Inc. - (OTC: CBNT)
C-Bond Systems markets patented nanotechnology to strengthen glass for automotive and structural uses. In 2025, it reports 15% revenue growth in NanoShield sales (web ID: 0). Its solutions for safety and durability position it for the $332.7 billion nanotechnology market, though OTC volatility and limited scale pose risks (post ID: 0).
Dotz Nano Ltd. - (OTCQB: DTZNY), (ASX: DTZ)
Dotz Nano develops carbon-based nanomaterials for CO2 capture and diagnostics. In 2025, it advances its Dotz Earth sorbent, reporting 20% stock growth (web ID: 21). Its sustainable nanotech positions it for the $332.7 billion nanotechnology market, though pre-revenue risks and project delays persist (post ID: 3).
First Graphene Limited - (ASX: FGR), (OTCQB: FGPHF)
First Graphene produces high-purity graphene for industrial applications, with 100-ton capacity. In 2025, it reports 12% revenue growth in battery additives (web ID: 16). Its scalable production positions it for the $332.7 billion nanotechnology market, though graphene commercialization challenges remain (post ID: 5).
Graphene Manufacturing Group Ltd. - (TSXV: GMG)
GMG develops graphene-enhanced batteries and HVAC coatings, with a focus on energy efficiency. In 2025, it reports 18% revenue growth in graphene aluminum-ion batteries (web ID: 16). Its sustainable solutions position it for the $332.7 billion nanotechnology market, though scale-up costs are a risk (post ID: 6).
Haydale Graphene Industries plc - (LSE: HAYD.L)
Haydale produces graphene-based composites for aerospace and biomedical applications. In 2025, it reports 10% revenue growth, driven by functional inks (web ID: 16). Its proprietary plasma process positions it for the $332.7 billion nanotechnology market, though small-cap financing risks persist (post ID: 7).
Nano Dimension Ltd. - (NASDAQ: NNDM)
Nano Dimension develops 3D-printed nanostructures for electronics, with $200 million in 2024 buybacks. In 2025, it reports 15% revenue growth, targeting additive manufacturing (web ID: 8). Its acquisition strategy positions it for the $332.7 billion nanotechnology market, though integration risks remain (web ID: 8).
NanoXplore Inc. - (TSX: GRA), (OTCQX: NNXPF)
NanoXplore produces graphene for batteries and composites, with 4,000 tons annual capacity. In 2025, it reports 12% revenue growth in EV applications (web ID: 19). Its scalable production positions it for the $332.7 billion nanotechnology market, though market adoption rates pose risks (post ID: 4).
PPG Industries, Inc. - (NYSE: PPG)
PPG, the world's largest coatings company, integrates nanoparticles in paints and aerospace coatings, with $18.2 billion in 2024 revenue. In 2025, it reports 5% growth in nanotech coatings (web ID: 11). Its R&D strength positions it for the $332.7 billion nanotechnology market, though raw material costs are a concern (web ID: 11).
Versarien plc - (LSE: VRS.L)
Versarien develops graphene-enhanced materials for construction and textiles. In 2025, it reports 8% revenue growth, focusing on lightweight composites (web ID: 16). Its collaborative projects position it for the $332.7 billion nanotechnology market, though commercialization delays and financing risks persist (post ID: 2).
Applied Materials, Inc. - (NASDAQ: AMAT)
Applied Materials supplies nanomanufacturing equipment for 2nm semiconductor chips, with $26.5 billion in 2024 revenue. In Q1 2025, it reports 6% revenue growth, driven by AI chip demand (web ID: 8). Its thin-film technology positions it for the $332.7 billion nanotechnology market, though semiconductor cyclicality poses risks (web ID: 8).
ASML Holding N.V. - (NASDAQ: ASML)
ASML produces EUV lithography machines for nanoscale chip production, with €27.6 billion in 2024 revenue. In 2025, it reports 8% growth, driven by 2nm node demand (web ID: 6). Its monopoly in EUV positions it for the $332.7 billion nanotechnology market, though geopolitical trade risks persist (web ID: 6).
KLA Corporation - (NASDAQ: KLAC)
KLA provides nanoscale inspection tools for semiconductor manufacturing, with $10.5 billion in 2024 revenue. In 2025, it reports 7% growth, driven by advanced node testing (web ID: 6). Its precision metrology positions it for the $332.7 billion nanotechnology market, though reliance on chipmakers poses risks (web ID: 6).
Lam Research Corporation - (NASDAQ: LRCX)
Lam Research supplies etching and deposition tools for nanoscale chip production, with $17.4 billion in 2024 revenue. In 2025, it reports 6% growth, driven by AI-driven chip demand (web ID: 6). Its advanced processes position it for the $332.7 billion nanotechnology market, though semiconductor market volatility is a risk (web ID: 6).
NVE Corporation - (NASDAQ: NVEC)
NVE develops spintronics-based nanosensors and memory chips for medical and industrial uses. In 2025, it reports 8% revenue growth, driven by sensor demand (web ID: 16). Its niche technology positions it for the $332.7 billion nanotechnology market, though limited market size poses risks (web ID: 16).
Taiwan Semiconductor Manufacturing Company Limited - (NYSE: TSM)
TSMC, the world's largest chip foundry, produces 2nm chips, with $75.8 billion in 2024 revenue. In 2025, it reports 10% growth, driven by AI and 5G demand (web ID: 6). Its nanoscale expertise positions it for the $332.7 billion nanotechnology market, though U.S.-China tensions pose risks (web ID: 6).
Tokyo Electron Limited - (Tokyo: 8035.T), (OTC: TOELY)
Tokyo Electron supplies nanoscale semiconductor equipment, with ¥2.2 trillion in 2024 revenue. In 2025, it reports 7% growth, driven by advanced chip nodes (web ID: 6). Its etching technology positions it for the $332.7 billion nanotechnology market, though reliance on Asian markets poses risks (web ID: 6).
Liquidia Corporation - (NASDAQ: LQDA)
Liquidia uses lithographic nanotechnology for precise nanoparticle drug delivery, focusing on pulmonary diseases. In 2025, it reports 12% revenue growth from PRINT technology (web ID: 2). Its biopharma pipeline positions it for the $332.7 billion nanotechnology market, though clinical trial risks remain (web ID: 2).
Nanobiotix S.A. - (NASDAQ: NBTX)
Nanobiotix develops nanoparticle-based cancer therapies, completing Phase 1 lung cancer trials in 2024. In $332.7 billion nanotechnology market, though clinical trial delays pose risks (web ID: 6; post ID: 1).
Selecta Biosciences, Inc. - (NASDAQ: SELB)
Selecta Biosciences uses nanoparticle-based ImmTOR for immune tolerance in gene therapies. In 2025, it advances autoimmune disease trials, reporting 10% stock growth (web ID: 2). Its platform positions it for the $332.7 billion nanotechnology market, though regulatory hurdles pose risks (web ID: 2).
Sona Nanotech Inc. - (CSE: SONA), (OTCQB: SNANF)
Sona Nanotech develops gold nanorods for cancer diagnostics and drug delivery. In 2025, it advances clinical trials, reporting 15% stock growth (web ID: 19). Its targeted therapies position it for the $332.7 billion nanotechnology market, though small-cap volatility and trial risks persist (post ID: 0).
Thermo Fisher Scientific Inc. - (NYSE: TMO)
Thermo Fisher supplies nanoscale tools for biopharma, with $42.5 billion in 2024 revenue. In 2025, its Stellar mass spectrometer drives 5% growth in nanomedicine (web ID: 9). Its R&D strength positions it for the $332.7 billion nanotechnology market, though high valuation poses risks (web ID: 9).
Zentek Ltd. - (NASDAQ: ZTEK), (TSXV: ZEN.V)
Zentek develops graphene-based nanocoatings for antimicrobial medical applications. In 2025, it reports 10% revenue growth in ZenGUARD coatings (web ID: 19). Its healthcare focus positions it for the $332.7 billion nanotechnology market, though regulatory approvals pose risks (post ID: 4).
Bruker Corporation - (NASDAQ: BRKR)
Our site does not give specific recommendations and encourages investors to complete their own due diligence. Our lists are compiled from internal and external research sources. Our lists are to be used only as a partial source of due diligence.
